Banque Cantonale Vaudoise Bio Rad Laboratories, Inc. Transaction History

Banque Cantonale Vaudoise

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$350.25 - $422.63 $26,268 - $31,697	75 Added 25.0%	375 $135,000
Q1 2023 Apr 20, 2023	SELL	$418.69 - $503.0 $334,952 - $402,400	-800 Reduced 72.73%	300 $144,000
Q4 2022 Feb 10, 2023	SELL	$351.71 - $456.01 $527,565 - $684,015	-1,500 Reduced 57.69%	1,100 $462,000
Q3 2022 Oct 17, 2022	BUY	$412.59 - $563.26 $41,259 - $56,326	100 Added 4.0%	2,600 $1.09 Million
Q2 2022 Aug 02, 2022	BUY	$463.67 - $597.16 $324,569 - $418,012	700 Added 38.89%	2,500 $1.24 Million
Q4 2021 Feb 14, 2022	SELL	$708.84 - $794.68 $354,420 - $397,340	-500 Reduced 21.74%	1,800 $1.36 Million
Q3 2021 Oct 29, 2021	SELL	$657.71 - $825.77 $1.12 Million - $1.4 Million	-1,700 Reduced 42.5%	2,300 $1.72 Million
Q2 2021 Aug 11, 2021	BUY	$576.64 - $649.04 $864,960 - $973,560	1,500 Added 60.0%	4,000 $2.58 Million
Q1 2021 May 11, 2021	BUY	$547.01 - $662.35 $765,814 - $927,290	1,400 Added 127.27%	2,500 $1.43 Million
Q4 2020 Feb 05, 2021	SELL	$510.68 - $643.45 $868,156 - $1.09 Million	-1,700 Reduced 60.71%	1,100 $641,000
Q3 2020 Oct 30, 2020	BUY	$454.43 - $535.6 $1.27 Million - $1.5 Million	2,800 New	2,800 $1.44 Million

453

18.3M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.74B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

Stay updated on Banque Cantonale Vaudoise with notifications on news.